GBA1 and Parkinson disease: Finally, based on the involvement of GBA mutations in the pathogenesis of Parkinson's disease, CRISPR/Cas9-based modeling systems have been used to show the importance of lysosomal function and lipid metabolism in the pathogenesis of this neurodegenerative disorder [23].